Schedule 13G ownership disclosure

ORIC Pharmaceuticals Inc

Security class unavailable · CUSIP: 68622P109

Event date: 2023-06-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,285,714
Percent of class
7.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-079126
Form type
SC 13G
Filer
Nextech Crossover I GP S.a r.l.
CIK
CIK 1916761
Filed
Jul 07, 2023
Reporting period
Jun 27, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub